Fredun Pharmaceuticals Limited has rescheduled its investor/analyst meeting from March 18 to March 25, 2026 at 12:00 PM, transitioning from a physical Mumbai meeting to a virtual format. The company has notified BSE Limited under Regulation 30 compliance, with Managing Director Fredun Nariman Medhora digitally signing the official communication dated March 21, 2026.
Fredun Pharmaceuticals Reschedules Investor Meeting to March 25, 2026 Virtual Format
